Studies that monitor PEDF levels in response to progressive neurological diseases like Amyotrophic Lateral Sclerosis (ALS) show that there is a significant upregulation of PEDF in the cerebrospinal fluid (CSF) of patients affected by the disease [121]. Here, SERPINF1 is linked to nervous system disorder.